Haemochromatosis gene mutations and response to chloroquine in sporadic porphyria cutanea tarda [18]

Acta Dermato-Venereologica

Volumn 86, Issue 3, 2006, Pages 279-280

  Toll, Agustin ^a,b   Celis, Raquel ^c   Ozalla, Maria Dolores ^a   Ercilla, M Guadalupe ^c   Herrero, Carmen ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

CONTROLLED STUDY; GENE MUTATION; HEMOCHROMATOSIS; HUMAN; LETTER; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MEDICAL RESEARCH; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL;

CHLOROQUINE; HEMOCHROMATOSIS; HUMANS; MEDICAL RECORDS; MUTATION; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; RETROSPECTIVE STUDIES; SPAIN;

EID: 33745018883     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0061     Document Type: Letter

References (10)

1. Legssyer R, Ward RJ, Crichton RR, Boelaert JR. Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages. Biochem Pharmacol 1999; 57: 907-911.
2. Kordac V, Semradova M. Treatment of porphyria cutanea tarda with chloroquine. Br J Dermatol 1974; 90: 95-100.
3. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the hemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-323.
4. Bonkowsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998; 27: 1661-1669.
5. Bulaj Z, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee DJ, et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000; 95: 1565-1571.
6. Chiaverini C, Halimi G, Ouzan D, Halfon P, Ortonne JP, Lacour JP. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France. Dermatology 2003; 206: 212-216.
7. Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 1998; 27: 181-184.
8. Enriquez de Salamanca R, Morales P, Castro MJ, Rojo R, Gonzalez M, Arnaiz-Villena A. The most frequent HFE allele linked to porphyria cutanea tarda in mediterraneans is His63Asp. Hepatology 1999; 30: 819-820.
9. Skowron F, Berard F, Grezard P, Wolf F, Morel Y, Perrot H. Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases. Ann Dermatol Venereol 2001; 128: 600-604.
10. Stölzel U, Kostler E, Schuppan D, Richter M, Wollina U, Doss MO, et al. Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda. Arch Dermatol 2003; 139: 309-313.